Avastin 25 mg/ml concentrate for solution for infusion., KEYTRUDA 25 mg/mL concentrate for solution for infusion. clinical trials

PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

This study looks at how well treatments for advanced cervical cancer work in the real world. It's called PROTECx and focuses on medicines like pembrolizumab (Keytruda) and bevacizumab (Avastin). Researchers want to understand how long patients live without their cancer growing and their quality of life.